Cited by 701Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration MechanismsNuclear Receptors and Signaling

The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.

Glial reactions in Parkinson's disease

McGeer, Patrick L., McGeer, Edith G.·2008·Movement Disorders

DOI 10.1002/mds.21751

Open this paper in CoChat — free account

Abstract

Dopaminergic neurons of the substantia nigra are particularly vulnerable to oxidative and inflammatory attack. Such processes may play a crucial role in the etiology of Parkinson disease (PD). Since glia are the main generators of these processes, the possibility that PD may be caused by glial dysfunction needs to be considered. This review concentrates on glial reactions in PD. Reactive astrocytes and reactive microglia are abundant in the substantia nigra (SN) of PD cases indicating a robust inflammatory state. Glia normally serve neuroprotective roles but, given adverse stimulation, they may contribute to damaging chronic inflammation. Microglia, the phagocytes of brain, may be the main contributors since they can produce large numbers of superoxide anions and other neurotoxins. Their toxicity towards dopaminergic neurons has been demonstrated in tissue culture and various animal models of PD. The MPTP and α‐synuclein models are of particular interest. Years after exposure to MPTP, inflammation has been observed in the SN. This has established that an acute insult to the SN can result in a sustained local inflammation. The α‐synuclein model indicates that an endogenous protein can induce inflammation, and, when overexpressed, can lead to autosomal dominant PD. Less is known about the role of astrocytes than microglia, but they are known to secrete both inflammatory and anti‐inflammatory molecules and may play a role in modulating microglial activity. Oligodendrocytes do not seem to play a role in promoting inflammation although, like neurons, they may be damaged by inflammatory processes. Further research concerning glial reactions in PD may lead to disease‐modifying therapeutic approaches. © 2007 Movement Disorder Society

Integrity signals

Registry

Crossref · 10.1002/mds.21751

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons
Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206
Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Self-citation
α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053

Flagged first, then by citations

Show all 106 references

Research works printed but not linked: 5

Del Rio Hortega P, 1919, El ‘tercer elemento’ de los centros nerviosos. Poder fagocitario y movilidad de la microglia, Bol Soc Esp Biol Ano, 154
LeWD RoweDB XieW.Activated microglia induce dopaminergic cell injury in vitro. In: Proceedings of the XIII International Congress on Parkinson's Disease Vancouver Canada July1999. pS19.
10.1111/j.1460-9568.2003.03014.x · DOI
10.1006/exnr.2002.7946 · DOI
10.1096/fj.05-5053com · DOI

Sorted by citations

Items 401–500 of 700

Potential role of α‐synuclein in neurodegeneration: studies in a rat animal model
Stoica, G., Lungu, G. F., Bjorklund, N. L., Taglialatela, G., Zhang, X., Chiu, V. M., Hill, H. H., Schenk, J. O., & Murray, I. V. J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07805.x · Cited by 29
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl 6-hydroxynaphthalene-2-carboxylate, a kojic acid derivative, inhibits inflammatory mediator production via the suppression of Syk/Src and NF-κB activation
Dung, T. T. M., Kim, S. C., Yoo, B. C., Sung, G., Yang, W. S., Kim, H. G., Park, J. G., Rhee, M. H., Park, K. W., Yoon, K., et al. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.02.019 · Cited by 29
Naphthazarin has a protective effect on the 1‐methyl‐4‐phenyl‐1,2,3,4‐tetrahydropyridine‐induced Parkinson's disease model
Choi, S. Y., Son, T. G., Park, H. R., Jang, Y. J., Oh, S. B., Jin, B., & Lee, J. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23061 · Cited by 29
Guanosine Protects Glial Cells Against 6-Hydroxydopamine Toxicity
Giuliani, P., Ballerini, P., Buccella, S., Ciccarelli, R., Rathbone, M. P., Romano, S., D’Alimonte, I., Caciagli, F., Iorio, P. D., & Pokorski, M. (2014) · Advances in experimental medicine and biology · doi:10.1007/5584_2014_73 · Cited by 28
Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs
Lillethorup, T. P., Glud, A. N., Alstrup, A. K. O., Mikkelsen, T. W., Nielsen, E. N., Zaer, H., Doudet, D. J., Brooks, D. J., Sørensen, J. C. H., Orłowski, D., et al. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.02.005 · Cited by 28
α-Synuclein Induces Progressive Changes in Brain Microstructure and Sensory-Evoked Brain Function That Precedes Locomotor Decline
Chu, W. T., DeSimone, J. C., Riffe, C. J., Liu, H., Chakrabarty, P., Giasson, B. I., Vedam‐Mai, V., & Vaillancourt, D. E. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0189-20.2020 · Cited by 28
Rosiglitazone Synergizes the Neuroprotective Effects of Valproic Acid Against Quinolinic Acid-Induced Neurotoxicity in Rats: Targeting PPARγ and HDAC Pathways
Mishra, J., Chaudhary, T., & Kumar, A. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9458-z · Cited by 29
A novel selective MAO-B inhibitor with neuroprotective and anti-Parkinsonian properties
Chan, H. H. N., Tse, M., Kumar, S. S., & Zhuo, L. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.023 · Cited by 28
CSF from Parkinson disease Patients Differentially Affects Cultured Microglia and Astrocytes
Schiess, M. C., Barnes, J. L., Ellmore, T. M., Poindexter, B. J., Dinh, K., & Bick, R. J. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-151 · Cited by 30
Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view
Sian‐Hülsmann, J., & Riederer, P. F. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-023-02723-5 · Cited by 30
Targeting α‐Synuclein as a therapy for Parkinson's disease: The battle begins
Olanow, C. W., & Kordower, J. H. (2017) · Movement Disorders · doi:10.1002/mds.26935 · Cited by 28
Model Senescent Microglia Induce Disease Related Changes in α-Synuclein Expression and Activity
Angelova, D. M., & Brown, D. R. (2018) · Biomolecules · doi:10.3390/biom8030067 · Cited by 30
Interferon-γ Involvement in the Neuroinflammation Associated with Parkinson’s Disease and L-DOPA-Induced Dyskinesia
Ferrari, D. P., Bortolanza, M., & Bel, E. A. D. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00345-x · Cited by 27
The role of mycotoxins in neurodegenerative diseases: current state of the art and future perspectives of research
Nguyen, V. T. T., König, S., Eggert, S., Endres, K., & Kins, S. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0214 · Cited by 28
Evidence of oligodendrogliosis in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced Parkinsonism
Annese, V., Barcia, C., Ros‐Bernal, F., Gómez, A., Ros, C. M. B., de Pablos, V., Fernández‐Villalba, E., Stefano, M. E. D., & Herrero, M. T. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01271.x · Cited by 30
Reversal of Rotenone-Induced Dysfunction of Astrocytic Connexin43 by Opening Mitochondrial ATP-Sensitive Potassium Channels
Zhang, S., Liang, R., Zhou, F., Huang, X., Ding, J., & Hu, G. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9560-6 · Cited by 27
Pathways towards an effective immunotherapy for Parkinson’s disease
Hutter-Saunders, J. A. L., Mosley, R. L., & Gendelman, H. E. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.163 · Cited by 28
6-Hydroxydopamine as a tool to understand adaptive immune system-induced dopamine neurodegeneration in Parkinson's disease
Theodore, S., & Maragos, W. F. (2015) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2015.1070172 · Cited by 27
Anti-neuroinflammatory effects of Eucommia ulmoides Oliv. In a Parkinson's mouse model through the regulation of p38/JNK-Fosl2 gene expression
Fan, S., Yin, Q., Li, D., Ma, J., Li, L., Chai, S., Guo, H. W., & Yang, Z. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113016 · Cited by 28
Unaltered lactate and glucose transporter levels in the MPTP mouse model of Parkinson's disease
Puchades, M. A., Sogn, C. J., Mæhlen, J., Bergersen, L. H., & Gundersen, V. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130190 · Cited by 26
Neurotoxins released from interferon-gamma-stimulated human astrocytes
Lee, M., McGeer, E. G., & McGeer, P. L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.033 · Cited by 26
Self-citation
Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease
Motyl, J. A., Strosznajder, J. B., Wencel, A., & Strosznajder, R. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126277 · Cited by 28
Effect of Subthalamic Stimulation and Electrode Implantation in the Striatal Microenvironment in a Parkinson’s Disease Rat Model
Campos, A. C. P., Martinez, R. C. R., Auada, A. V. V., Lebrun, I., Fonoff, E. T., Hamani, C., & Pagano, R. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012116 · Cited by 27
Licorice-derived dehydroglyasperin C increases MKP-1 expression and suppresses inflammation-mediated neurodegeneration
Kim, J., Kim, J., Shim, J., Lee, S., Kim, J., Lim, S. S., Lee, K. W., & Lee, H. J. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.09.013 · Cited by 26
Astrocytes: inexplicable cells in neurodegeneration
Singh, S., & Joshi, N. (2016) · International Journal of Neuroscience · doi:10.3109/00207454.2016.1173692 · Cited by 26
Pooled analysis of the HLA‐DRB1 by smoking interaction in Parkinson disease
Chuang, Y., Lee, P., Vlaar, T., Mulot, C., Loriot, M., Hansen, J., Lill, C. M., Ritz, B. R., & Elbaz, A. (2017) · Annals of Neurology · doi:10.1002/ana.25065 · Cited by 29
NSAID Use and the Risk of Parkinsons Disease
Etminan, M., & Suissa, S. (2006) · Current Drug Safety · doi:10.2174/157488606777934404 · Cited by 26
Alterations of Glial Cells in the Mouse Hippocampus During Postnatal Development
Kimoto, H., Eto, R., Abe, M., Kato, H., & Araki, T. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9412-4 · Cited by 26
Protective Effects of Alpha-Lipoic Acid on Glutamate-Induced Cytotoxicity in C6 Glioma Cells
Park, E., Gim, J., Kim, D. K., Kim, C., & Chun, H. S. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00603 · Cited by 26
Angelicae Gigantis Radix Regulates LPS-Induced Neuroinflammation in BV2 Microglia by Inhibiting NF-κB and MAPK Activity and Inducing Nrf-2 Activity
Oh, Y.-C., Jeong, Y. H., Li, W., & Go, Y. (2019) · Molecules · doi:10.3390/molecules24203755 · Cited by 25
6-Hydroxydopamine Induces Abnormal Iron Sequestration in BV2 Microglia by Activating Iron Regulatory Protein 1 and Inhibiting Hepcidin Release
Xu, M., Li, Y., Meng, D., Zhang, D., Wang, B., Xie, J., & Wang, J. (2022) · Biomolecules · doi:10.3390/biom12020266 · Cited by 25
Peripheral inflammation and neurodegeneration; a potential for therapeutic intervention in Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS)
Hanna, L., Poluyi, E., Ikwuegbuenyi, C. A., Morgan, E., & Imaguezegie, G. (2022) · The Egyptian Journal of Neurosurgery : the official publication of the Egyptian Society of Neurological Surgeons/Egyptian journal of neurosurgery · doi:10.1186/s41984-022-00150-4 · Cited by 30
The effect of guggulipid and nimesulide on MPTP-induced mediators of neuroinflammation in rat astrocytoma cells, C6
Niranjan, R., Rajasekar, N., Nath, C., & Shukla, R. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.08.008 · Cited by 25
Immune effects of optimized DNA vaccine and protective effects in a MPTP model of Parkinson’s disease
Chen, Z., Yang, Y., Xu, Y., Zhou, C., Li, F., Peng, L., Zhong, L., Jin, X., & Peng, G. (2013) · Neurological Sciences · doi:10.1007/s10072-012-1284-6 · Cited by 25
Hippocampal proliferation is increased in presymptomatic Parkinson’s disease and due to microglia
Doorn, K. J., Drukarch, B., van Dam, A.-M., & Lucassen, P. J. (2014) · Neural Plasticity · doi:10.1155/2014/959154 · Cited by 24
Reconsidering the role of glial cells in chronic stress-induced dopaminergic neurons loss within the substantia nigra? Friend or foe?
Ong, L. K., Zhao, Z., Kluge, M. G., TeBay, C., Zalewska, K., Dickson, P. W., Johnson, S. J., Nilsson, M., & Walker, F. R. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.10.001 · Cited by 27
How dependent is synaptic plasticity on microglial phenotype?
Jones, R. S., & Lynch, M. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.08.012 · Cited by 25
Folate deprivation induced neuroinflammation impairs cognition
Shaikh, A., & Roy, H. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137264 · Cited by 25
mTOR Pathway – Novel Modulator of Astrocyte Activity
Latacz, A., Russell, J. A., Oclon, E. A., Zubel–Łojek, J., & Pierzchała, K. (2015) · Folia Biologica · doi:10.3409/fb63_2.95 · Cited by 23
Protection by glia-conditioned medium in a cell model of Huntington disease
Ruíz, C., Casarejos, M. J., Gómez, A., Solano, R. M., de Yébenes, J. G., & Mena, M. A. (2012) · PLoS Currents · doi:10.1371/4fbca54a2028b · Cited by 23
Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential?
Gil-Martínez, A. L., Cuenca‐Bermejo, L., Sánchez, C., Estrada, C. M., Fernández‐Villalba, E., & Herrero, M. T. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1357-4 · Cited by 23
Prothrombin kringle-2-induced oxidative stress contributes to the death of cortical neurons in vivo and in vitro: Role of microglial NADPH oxidase
Won, S.-Y., Choi, S., & Jin, B. K. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.07.005 · Cited by 21
Pharmacological, Biochemical and Immunological Studies on Protective Effect of Mangiferin in 6-Hydroxydopamine (6-OHDA)-Induced Parkinson’s Disease in Rats
Tiwari, P. C., Chaudhary, M. J., Pal, R., Kartik, S., & Nath, R. (2021) · Annals of Neurosciences · doi:10.1177/09727531211051976 · Cited by 23
Prevention of L-Dopa-Induced Dyskinesias by MPEP Blockade of Metabotropic Glutamate Receptor 5 Is Associated with Reduced Inflammation in the Brain of Parkinsonian Monkeys
Morissette, M., Bourque, M., Tremblay, M., & Paolo, T. D. (2022) · Cells · doi:10.3390/cells11040691 · Cited by 22
Neuroprotective Effect of Swertiamarin in a Rotenone Model of Parkinson's Disease: Role of Neuroinflammation and Alpha-Synuclein Accumulation.
Sharma, M., Malim, F., Goswami, A., Sharma, N., Juvvalapalli, S. S., Chatterjee, S., Kate, A., & Khairnar, A. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00120 · Cited by 21
Astrocytes Role in Parkinson: A Double-Edged Sword
Cabezas, R., Fidel, M., Torrente, D., El-Bachá, R. D. S., Morales, L., González, J., & George, E. (2013) · InTech eBooks · doi:10.5772/54305 · Cited by 22
Guanosine exerts neuroprotective effects by reversing mitochondrial dysfunction in a cellular model of Parkinson’s disease
Li, D., YAO, M., Dong, Y., TANG, M.-N., CHEN, W., Guang-ren, L., & SUN, B.-Q. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1904 · Cited by 22
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease
Armentero, M., Levandis, G., Bazzini, E., Cerri, S., Ghezzi, C., & Blandini, F. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.05.017 · Cited by 22
The potential of light therapy in Parkinson's disease
Mitrofanis, J., Johnstone, D. M., Moro, C., Torres-Martinez, N., Eells, J. T., Ashkan, K., Stone, J., Benabid, A., & Coleman, K. A. (2014) · ChronoPhysiology and Therapy · doi:10.2147/cpt.s57180 · Cited by 22
TLR4 signaling mediates AP-1 activation in an MPTP-induced mouse model of Parkinson's disease
Zhao, X., Wang, F.-X., Cao, W., Zhang, Y., & Li, Y. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.01.010 · Cited by 23
Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum
Pattarini, R., Rong, Y., Qu, C., & Morgan, J. I. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.064 · Cited by 22
“Reframing” dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications
Marchetti, B., Giachino, C., Tirolo, C., & Serapide, M. F. (2022) · Aging Cell · doi:10.1111/acel.13575 · Cited by 22
Astrocyte-specific IKK2 activation in mice is sufficient to induce neuroinflammation but does not increase susceptibility to MPTP
Oeckl, P., Lattke, M., Wirth, T., Baumann, B., & Ferger, B. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.010 · Cited by 24
Postnatal Development of Neurons, Interneurons and Glial Cells in the Substantia Nigra of Mice
Abe, M., Kimoto, H., Eto, R., Sasaki, T., Kato, H., Kasahara, J., & Araki, T. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9521-0 · Cited by 21
Proteomics as a new paradigm to tackle Parkinson’s disease research challenges
Licker, V., & Burkhard, P. R. (2014) · Translational Proteomics · doi:10.1016/j.trprot.2014.08.001 · Cited by 21
Molecular Imaging of Neuroinflammation in Idiopathic Parkinson's Disease
Roussakis, A., & Piccini, P. P. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.08.009 · Cited by 23
Asparagine endopeptidase inhibitor protects against fenpropathrin-induced neurodegeneration via suppressing α-synuclein aggregation and neuroinflammation
Yu, T., Wan, F. J., Liu, C., Zhang, X., Liu, Z., Zhang, J., Xiong, J., Wang, T., & Zhang, Z. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173586 · Cited by 22
Neuroinflammation-Induced Upregulation of Glial Cathepsin X Expression and Activity in vivo
Pišlar, A. H., Tratnjek, L., Glavan, G., Zidar, N., Živin, M., & Kos, J. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.575453 · Cited by 21
Intranasal Rotenone Induces Alpha-Synuclein Accumulation, Neuroinflammation and Dopaminergic Neurodegeneration in Middle-Aged Mice
Sharma, M., Sharma, N., & Khairnar, A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03847-y · Cited by 20
Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson’s Disease
Pišlar, A. H., Tratnjek, L., Glavan, G., Živin, M., & Kos, J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00412 · Cited by 20
Erythropoietin modulates striatal antioxidant signalling to reduce neurodegeneration in a toxicant model of Parkinson's disease
Thompson, A., Farmer, K., Rowe, E. M., & Hayley, S. P. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103554 · Cited by 20
Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice
Xu, X., Song, N., Wang, R., Jiang, H. F., & Xie, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9437-2 · Cited by 20
Neuroprotective Effects of Cuscutae Semen in a Mouse Model of Parkinson’s Disease
Ye, M., Lee, S. G., Chung, E. S., Lim, S.-J., Kim, W. S., Yoon, H., Kim, S. K., Ahn, K. S., Jang, Y. P., & Bae, H. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/150153 · Cited by 20
Parkinson’s Disease With Depression: The Correlations Between Neuroinflammatory Factors and Neurotransmitters in Cerebrospinal Fluid
Lian, T., Guo, P. F., Zhang, Y., Li, J., Li, L., Ding, D.-Y., Li, D.-N., Zhang, W., Guan, H., Wang, X., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.574776 · Cited by 20
Post-mortem brain histological examination in the substantia nigra and subthalamic nucleus in Parkinson’s disease following deep brain stimulation
Mazumder, S., Bahar, A. Y., Shepherd, C. E., & Prasad, A. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.948523 · Cited by 19
The role of α-synuclein in neurodegeneration — An update
Jellinger, K. A. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0013-1 · Cited by 19
Targeting α-synuclein as a therapeutic strategy for Parkinson’s disease
Lawand, N., Saadé, N. E., El‐Agnaf, O. M. A., & Safieh‐Garabedian, B. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1062877 · Cited by 19
Amitriptyline protects against TNF ‐α‐induced atrophy and reduction in synaptic markers via a Trk‐dependent mechanism
O'Neill, E., Kwok, B., Day, J. S., Connor, T. J., & Harkin, A. (2016) · Pharmacology Research & Perspectives · doi:10.1002/prp2.195 · Cited by 20
Harnessing the immune system for the treatment of Parkinson’s disease
Vedam‐Mai, V. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147308 · Cited by 20
Neurological and psychiatric disorders as a neuroglial failure.
Verkhratsky, A., & Parpura, V. (2014) · PubMed · Cited by 19
Neurotoxic factors released by stimulated human monocytes and THP-1 cells
Lee, M., Suk, K., Kang, Y., McGeer, E. G., & McGeer, P. L. (2011) · Brain Research · doi:10.1016/j.brainres.2011.05.021 · Cited by 19
Self-citation
Towards New Therapies for Parkinson's Disease
Finkelstein, D. I. (2011) · InTech eBooks · doi:10.5772/954 · Cited by 19
Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson’s disease
Bahdoudi, S., Ghouili, I., Hmiden, M., do Rego, J. L., Lefranc, B., Leprince, J., Chuquet, J., do-Rego, J.-C., Marcher, A.-B., Mandrup, S., et al. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2727-2 · Cited by 19
Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease
Schlachetzki, J. C. M., Marxreiter, F., Regensburger, M., Kulinich, A. O., Winner, B., & Winkler, J. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-130371 · Cited by 19
Agaricus blazei extract abrogates rotenone-induced dopamine depletion and motor deficits by its anti-oxidative and anti-inflammatory properties in Parkinsonic mice
Gobi, V. V., Rajasankar, S., Ramkumar, M., Dhanalakshmi, C., Manivasagam, T., Thenmozhi, A. J., Essa, M. M., Chidambaram, R., & Kalandar, A. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1337290 · Cited by 18
Cellular phenotypes as inflammatory mediators in Parkinson’s disease: Interventional targets and role of natural products
Jiang, X., Ganesan, P., Rengarajan, T., Choi, D., & Arulselvan, P. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.162 · Cited by 19
Imaging neuroinflammation in Alzheimer’s and other dementias: recent advances and future directions
Brooks, D. J. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.01.049 · Cited by 17
EEF1A1 is Involved the Regulating Neuroinflammatory Processes in Parkinson's Disease
Aisha, Z., Lei, J., Zhang, Y., & Ma, J. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2205122 · Cited by 17
Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease
Kulski, J. K., Suzuki, S., Shiina, T., Pfaff, A. L., & Kõks, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1349030 · Cited by 18
Ncx3-Induced Mitochondrial Dysfunction in Midbrain Leads to Neuroinflammation in Striatum of A53t-α-Synuclein Transgenic Old Mice
Martino, R. D., Sisalli, M. J., Sirabella, R., Notte, S. D., Borzacchiello, D., Feliciello, A., Annunziato, L., & Scorziello, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158177 · Cited by 17
Low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor-κB reporter mice prior to loss of dopaminergic neurons
Miller, J. A., Trout, B. R., Sullivan, K. A., Bialecki, R., Roberts, R. A., & Tjalkens, R. B. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22549 · Cited by 17
Pathology of Parkinson's Disease
Halliday, G. M., & Murphy, K. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00009-x · Cited by 17
The Plant Phenolic Diterpene Carnosol Suppresses Sodium Nitroprusside-Induced Toxicity in C6 Glial Cells
Kim, S. Y., Park, E., Park, J. A., Choi, B.-S., Kim, S., Jeong, G., Kim, C., Kim, D. K., Kim, S.-J., & Chun, H. S. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf903294x · Cited by 16
Overview of pro-inflammatory and pro-survival components in neuroinflammatory signalling and neurodegeneration
Kardam, S., Ambasta, R. K., & Kumar, P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102465 · Cited by 17
Lactiplantibacillus plantarum SG5 inhibits neuroinflammation in MPTP-induced PD mice through GLP-1/PGC-1α pathway
Qi, Y., Dong, Y., Chen, J., Xie, S., Ma, X., Yu, X., Yu, Y., & Wang, Y. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115001 · Cited by 17
Neuroprotective and plasticity promoting effects of repetitive transcranial magnetic stimulation (rTMS): A role for microglia
d’Errico, P., Früholz, I., Meyer‐Luehmann, M., & Vlachos, A. (2025) · Brain stimulation · doi:10.1016/j.brs.2025.03.012 · Cited by 19
Associations of Matrix Metalloproteinase-9 and Tissue Inhibitory Factor-1 Polymorphisms With Parkinson Disease in Taiwan
Chen, Y., Wu, Y., Mesri, M., & Chen, C. (2016) · Medicine · doi:10.1097/md.0000000000002672 · Cited by 19
Senescence marker protein 30 deficiency increases Parkinson's pathology by impairing astrocyte activation
Kim, H. S., Son, T. G., Park, H. R., Lee, Y., Jung, Y., Ishigami, A., & Lee, J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.008 · Cited by 16
A Novel Immunosuppressor, (5R)-5-Hydroxytriptolide, Alleviates Movement Disorder and Neuroinflammation in a 6-OHDA Hemiparkinsonian Rat Model
Su, R., Sun, M. K., Wang, W., Zhang, J., Zhang, L., Zhen, J., Qian, Y., Zheng, Y., & Wang, X. (2017) · Aging and Disease · doi:10.14336/ad.2016.0929 · Cited by 16
Oxidative Stress in Parkinson's Disease
Vaya, J., Aluf, Y., & Finberg, J. P. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-514-9_12 · Cited by 16
Research progress on intranasal treatment for Parkinson's disease
Wen, P., & Ren, C. (2024) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.42 · Cited by 18
Transient glutathione depletion in the substantia nigra compacta is associated with neuroinflammation in rats
Díaz-Hung, M.-L., Yglesias-Rivera, A., Hernández-Zimbrón, L. F., Orozco-Suárez, S. A., Ruiz-Fuentes, J. L., Díaz-García, A., León-Martínez, R., Blanco-Lezcano, L., Fuentes, N. P., & Pedré, L. L. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.023 · Cited by 15
Acute lysine overload provokes marked striatum injury involving oxidative stress signaling pathways in glutaryl-CoA dehydrogenase deficient mice
Amaral, A. U., Seminotti, B., da Silva, J. C., de Oliveira, F. H., Ribeiro, R. T., Leipnitz, G., Souza, D. O., & Wajner, M. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104467 · Cited by 15
Substantia nigra echogenicity in Parkinson’s disease: relation to serum iron and C-reactive protein
Walter, U., Witt, R., Wolters, A., Wittstock, M., & Benecke, R. (2011) · Journal of neural transmission · doi:10.1007/s00702-011-0664-z · Cited by 17
Differences in brain pathological changes between rotenone and 6-hydroxydopamine Parkinson’s disease models
Liu, L., Du, D., Wang, Z., Fang, Y., Zheng, T., Dong, Y., Shi, Q., Zhao, M., Xiao, F., & Du, J. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.235076 · Cited by 15
Pyruvate Prevents Dopaminergic Neurodegeneration and Motor Deficits in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson’s Disease
Kim, Y., Choi, S. Y., Hwang, O., & Lee, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03017-9 · Cited by 14
The interplay between α-synuclein aggregation and necroptosis in Parkinson’s disease: a spatiotemporal perspective
Xiang, H. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1567445 · Cited by 18
Overexpression of Annexin A1 Suppresses Pro-Inflammatory Factors in PC12 Cells Induced by 1-Methyl-4-Phenylpyridinium.
Kiani‐Esfahani, A., Kazemi, S., Peymani, M., Hashemi, M., Ghaedi, K., & Nasr‐Esfahani, M. H. (2016) · Europe PMC (PubMed Central) · doi:10.22074/cellj.2016.4314 · Cited by 14
NF ‐κB activation mediates LPS ‐or zymosan‐induced hypotension and inflammation reversed by BAY 61‐3606, a selective Syk inhibitor, in rat models of septic and non‐septic shock
Fırat, S. Ş., Temiz-Reşitoğlu, M., Güden, D. S., Şenol, Ş. P., Sari, A. N., Cil, M., Unsal, D., Korkmaz, B., Tunçtan, B., Malik, K. U., et al. (2018) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13045 · Cited by 14
Boerhavia diffusa L. ethanol extract suppresses inflammatory responses via inhibition of Src/Syk/TRAF6
Thai, H. V., Kim, E., Kim, S. C., Jeong, D., Yang, S., Baek, K., Kim, Y., Ratan, Z. A., Yoon, K. D., Kim, J., et al. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.06.004 · Cited by 14

Authors: McGeer, P. L., & McGeer, E. G.
Affiliations: University of British Columbia (CA)
Corresponding author: McGeer, Patrick L.
ORCID: McGeer, Patrick L.
Venue: Movement Disorders
Publisher: Wiley
Published: 2007-11-28
Volume: 23
Issue: 4
Pages: 474-483
ISSN: 0885-3185 (ISSN-L)
1531-8257
DOI: 10.1002/mds.21751
OpenAlex: W2120412340
Cited by: 701
References: 106
Citations by year: 2026: 9 · 2025: 23 · 2024: 20 · 2023: 20 · 2022: 36 · 2021: 26 · 2020: 39 · 2019: 22 · 2018: 42 · 2017: 34 · 2016: 48 · 2015: 39 · 2014: 58 · 2013: 40 · 2012: 63
FWCI: 5.11
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Movement Disorders (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords: Parkinson's disease, glial reaction, reactive astrocytes, reactive microglia, substantia nigra, dopaminergic neurons, neuroinflammation, oxidative stress, MPTP, alpha-synuclein, oligodendrocytes, neuroprotection, disease-modifying therapy
MeSH terms: Animals, Haplorhini, Anti-Inflammatory Agents, Non-Steroidal, Astrocytes, Brain, Dopamine, Female, HLA-DR Antigens, Humans, Immunohistochemistry, Inflammation, Male, Neurons, Neurotoxins, Parkinson Disease, Substantia Nigra, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Microglia, Oxidative Stress, Intercellular Adhesion Molecule-1, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Glial reactions in Parkinson's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks